AFM24 in Combination with Autologous NK Cells (SNK01) in Patients with Advanced/metastatic Epidermal Growth Factor Receptor (EGFR) Expressing Solid Tumors: Initial Results from the Phase 1 Dose-Escalation Study.
JCO global oncology（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined